Strattera

Atomoxetine

For ADHD

Track record

More

Long (approved in 2002)

Special FDA warning?

More

Yes - FDA requires black box warning

Bottom line

More

ADHD

What is ADHD?

More

It’s normal for children to have difficulty paying attention and controlling their behavior at times. What should lead you to suspect ADHD is a persistent pattern lasting at least six months of abnormally high levels of physical activity (hyperactivity), impulsivity, and/or lack of ability to pay attention and focus or complete tasks.

Other treatments for ADHD

More

Non-drug

Over-the-counter

Prescription

TABLE OF CONTENTS

Overview

FDA-approved use

To reduce the symptoms of attention deficit hyperactivity disorder (ADHD)

If Strattera is used it should be part of a total treatment program for ADHD that may include counseling or other therapies

Who might consider taking it?

Adults, adolescents, and children with ADHD

What is not known

Strattera is not meant for use in the those with ADHD due to environmental factors and/or other psychiatric disorders, including psychosis

Track record

LONG TRACK RECORD

Long track record means that new‚ unexpected side effects are unlikely. Strattera was approved by FDA in 2002. Since Strattera has now been used by large numbers of people over a long time‚ the emergence of rare but serious side effects is less likely than with new drugs.

Open questions

No FDA-required studies at approval

Do not take if you...

Are allergic to atomoxetine

Take a depression medicine called a monoamine oxidase inhibitor (MAOI)

Don't take Strattera if you have taken a MAOI within the past 14 days

Have narrow angle glaucoma

Have or have had an adrenal gland tumor called a pheochromocytoma

Have serious heart or vascular disease

These conditions might get worse with increased blood pressure or heart rate that can happen with Strattera

Safe if pregnant or breastfeeding?

Pregnant

Only take if potential benefits outweigh potential harm to baby (FDA Category C)

Breastfeeding

Unknown if Strattera gets into breast milk

NEXT: TRIALS

Want to View More Content?